Otosclerosis 2: the medical management of otosclerosis.
The rationale for medical therapy for otospongiosis is to slow down and eventually stop the phase of bone resorption. There is some increase in the incidence of stapedial otospongiosis in a low-fluoride area compared with a high-fluoride area. Sodium fluoride treatment has a role to play in preventing the onset and progression of hearing loss in patients suffering from otosclerosis. Sodium fluoride therapy has been shown to have some beneficial effect on dizziness associated with otosclerosis. In view of the possibility of systemic side effects of sodium fluoride therapy, a regular follow up of patients is warranted. Biphosphonates can be used as an alternative treatment to sodium fluoride in cases where the patient is intolerant to sodium fluoride therapy. Hearing aid is also a treatment option, but it does not halt the disease process.
Uppal
S
S
Department of ENT, York Hospital, York, UK. uppalsandeep@yahoo.com
Bajaj
Y
Y
Coatesworth
A P
AP
D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D010040:Otosclerosis / Q000188:drug therapy*; D012969:Sodium Fluoride / Q000627:therapeutic use; D014012:Tinnitus / Q000188:drug therapy / Q000209:etiology; D016896:Treatment Outcome; D014717:Vertigo / Q000188:drug therapy / Q000209:etiology
D004164:Diphosphonates; D012969:Sodium Fluoride